Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021
Tag: LinearDNA
Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications
November 2nd, 2020
Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment
July 9th, 2020
Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
June 9th, 2020
APDN Provides Update on Linear-DNA COVID-19 Vaccine Candidates
June 8th, 2020
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 21st, 2020
New Highly Sensitive COVID-19 Clinical Test Now in Use at Stony Brook
May 18th, 2020
FDA grants EUA for COVID-19 molecular tests
May 18th, 2020
APDN Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 15th, 2020